Ark and AOTI sign chronic wound agreement
This article was originally published in Clinica
Executive Summary
Woundcare firm AOTI is to combine its topical wound oxygen therapy (TWO2) extremity chambers with Ark Therapeutics’ Kerraboot dressing device in a bid to enhance treatment for problematic chronic wounds.